The tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) and MMP-9 can be used as potential diagnostic biomarkers for sepsis-associated AKI in clinical assessment (Bojic et al., 2015). This evidence concerns the gene MMP9 and acute kidney injury.